ORFADIN 4 mg/ml, oral suspension bottle, 90 ml
Active ingredients: Nitisinone
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 90 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ORFADIN 4 mg/ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) avec fermeture de sécurité enfant de 90 ml avec adaptateur(s) pour flacon avec seringue(s) pour administration orale
- Marketing authorisation holder
- SWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Jun 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66880925CIP73003391CIP133400930033913Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NITISINONEsuspension | 4 mg · 1 ml de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.